Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,824 | 1,198 | 1,378 | 3,026 | 1,723 |
| Marketable Securities | N/A | N/A | 0 | 98 | 227 |
| Receivables | 28 | 39 | 92 | 137 | 225 |
| Inventories | 1,510 | 1,540 | 1,925 | 2,636 | 2,641 |
| Other current assets | 1,045 | 928 | 188 | 220 | 262 |
| TOTAL | $4,407 | $3,705 | $3,583 | $6,117 | $5,078 |
| Non-Current Assets | |||||
| PPE Net | 3,586 | 3,695 | 5,268 | 7,947 | 8,104 |
| Intangibles | 1,720 | 1,616 | 1,182 | 1,181 | 1,179 |
| Other Non-Current Assets | 881 | 886 | 1,226 | 1,261 | 1,312 |
| TOTAL | $6,187 | $6,197 | $7,676 | $10,389 | $10,595 |
| Total Assets | $10,594 | $9,902 | $11,259 | $16,506 | $15,673 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 771 | 773 | 648 | 549 | 672 |
| Accrued Expenses | 1,718 | 1,567 | 1,288 | 1,557 | 1,459 |
| TOTAL | $2,489 | $2,340 | $1,936 | $2,106 | $2,131 |
| Non-Current Liabilities | |||||
| Long Term Debt | 136 | 137 | 138 | 139 | 140 |
| Other Non-Current Liabilities | 89 | 104 | 132 | 163 | 200 |
| TOTAL | $225 | $241 | $270 | $302 | $340 |
| Total Liabilities | $2,714 | $2,581 | $2,206 | $2,408 | $2,471 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 75,636 | 75,636 | 63,734 | 63,734 | 53,917 |
| Common Shares | 127,349 | 124,409 | 123,258 | 122,732 | 119,322 |
| Retained earnings | -116,043 | -113,665 | -110,780 | -105,191 | -102,740 |
| Other shareholders' equity | -3,426 | -3,423 | -3,425 | -3,443 | -3,380 |
| TOTAL | $7,880 | $7,321 | $9,053 | $14,098 | $13,202 |
| Total Liabilities And Equity | $10,594 | $9,902 | $11,259 | $16,506 | $15,673 |